They focus in real estate investment and medical service Growing fast
The flat volume should be increasing any day, for better or worse. I'm thinking for better. It has built strong support on the 100 day, & RSI is trending up while price is riding an upward trend line. It looks decent, and now is a good time for a lot of stocks to break out of their slumps. I'm noticing numerous stocks at a tipping point so I think Monday or...
INVO potential day trade. I may enter above the 5.85 for a price target of 7.45 on a bounce up from support. It appears that volume is concentrated at two primary levels, this trade attempts to profit on that spread. (Just an idea, not advice)
The rising reverse wedge pattern highlights common lower support and higher resistance trend. A pattern has emerged where the price appears to spike on/around the 9th and 21st of the month and the price seems to rise up to the next level of the fibonacci retracement (Support/Resistance). I would consider taking a long position at the $3.50 level for a potential...
APHA (Aphria, Inc.) is rebounding up from a support line on the year to date rising fibonacci channel. It is probable that APHA will continue it's upward momentum up to 17.81 for an approximate 13% gain (+/-) upon where it would encounter the yearly 61.8% fibonacci resistance level. If APHA crosses above 17.81, the Point of control (POC) where volume is most...
Zomedica looks like it will be a winner once its veterinarian office lab testing product launches on March 30 . ZOM stock is already up 850% so far this year. In fact, it peaked at $2.70 in early February in anticipation of this product launch.Moreover, the company has very smart about taking advantage of its huge price spike. On Feb. 8, it raised another $185.4...
SENS still has some room to run. The price targets are based off of the extended support and resistances of the run up to previous all time highs. Pull backs within the up trend can be expected to retrace to underlying lines drawn when price moves above.
BioNano Genomics - breakout - possible Q1/Q2 mitd-term route
CureVac - bullish - Q1 - mid-term possbile route - many shares have the same formation right now.. with a more likely breakout on top
If it breaks the 13.29 Resistance point, goes to mars. All it needs is more good news (which come every week) and a good volume. Lets Go!
Can you see some volume patterns? This was my first NAKD Naked Brand post: GBT Researching AI based, Robotics Technology for the Medical Field GBT Researching a Development of a Radio Based Computer Vision System For Cardiovascular Applications GBT Tokenize Corp Evaluating qTerm Applications for Hotel Industry GBT Developing a Long-Range Radio System Targeting...
Teladoc is close to 253 resistance tested in Aug 2020. It's clearly bullish, but is there more to go? Wait and see.
Nice consolidation here, candle shadows seem to show sell pressure, which should lead to a bigger breakout.
Hello Tradingviewians, CMS has been in a long consolidation to digest lowering growth rates. Additionally it has been under fire by short sellers, alleging CMS of faking revenue numbers. Should the numbers be genuine, and factors like consistent insider buying suggest it, CMS represents serious value at this point. Technically, a two year downtrend collides with...
LABU Long analysis on the monthly. Looks like a lot of accumulation looking to breakout biggins.
Has been working its way up for a while and may be ready for a bigger move.
support level at 3.20 Resistance 1 : 3.50 Resistance 2 : 3.85 medical gloves are on demand globally so investing in careplus till 2021 shouldn’t be an issue. *Profitable company * If you bought at the higher price my suggestion is use this formula call (buy on deep) Buy On deep at 3.25 It’s helps you to lower your total unit price (Lower price vs more units...